Business
RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial
RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial
About this update from Radiopharm Theranostics Limited
Radiopharm Theranostics Limited has released a press release. View Attachment
View stock analysis, news, and events for Radiopharm Theranostics Limited
More from Radiopharm Theranostics Limited
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202...
August 20, 2026
Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases
August 17, 2026